Search Results

There are 17177 results for: content related to: CSF biomarkers for mild cognitive impairment

  1. Strong Inhibition of Beta-Amyloid Peptide Aggregation Realized by Two-Steps Evolved Peptides

    Chemical Biology & Drug Design

    Volume 85, Issue 3, March 2015, Pages: 356–368, Sunita Ghimire Gautam, Masayuki Komatsu and Koichi Nishigaki

    Version of Record online : 11 SEP 2014, DOI: 10.1111/cbdd.12400

  2. Aβ42 and Aβ40: similarities and differences

    Journal of Peptide Science

    Volume 21, Issue 7, July 2015, Pages: 522–529, Tian Qiu, Qian Liu, Yong-Xiang Chen, Yu-Fen Zhao and Yan-Mei Li

    Version of Record online : 28 MAY 2015, DOI: 10.1002/psc.2789

  3. CSF tau protein and β-amyloid (1–42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population

    European Journal of Neurology

    Volume 10, Issue 2, March 2003, Pages: 119–128, E. Kapaki, G. P. Paraskevas, I. Zalonis and C. Zournas

    Version of Record online : 26 FEB 2003, DOI: 10.1046/j.1468-1331.2003.00562.x

  4. Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio

    Journal of Peptide Science

    Volume 19, Issue 9, September 2013, Pages: 545–553, Md. Shahnawaz, Md. Golam Sharoar, Song Yub Shin and Il-Seon Park

    Version of Record online : 13 JUL 2013, DOI: 10.1002/psc.2531

  5. You have full text access to this OnlineOpen article
    CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?

    Annals of Clinical and Translational Neurology

    Volume 2, Issue 2, February 2015, Pages: 131–139, William T. Hu, Kelly D. Watts, Leslie M. Shaw, Jennifer C. Howell, John Q. Trojanowski, Sundeep Basra, Jonathan D. Glass, James J. Lah and Allan I. Levey

    Version of Record online : 19 DEC 2014, DOI: 10.1002/acn3.160

  6. Disclosure of a fundamental clue for the elucidation of the myricetin mechanism of action as amyloid aggregation inhibitor by mass spectrometry


    Volume 33, Issue 22, November 2012, Pages: 3380–3386, Jessica Fiori, Marina Naldi, Manuela Bartolini and Vincenza Andrisano

    Version of Record online : 10 SEP 2012, DOI: 10.1002/elps.201200186

  7. You have full text access to this OnlineOpen article
    Preoperative cerebrospinal fluid β-Amyloid/Tau ratio and postoperative delirium

    Annals of Clinical and Translational Neurology

    Volume 1, Issue 5, May 2014, Pages: 319–328, Zhongcong Xie, Celeste A. Swain, Sarah A. P. Ward, Hui Zheng, Yuanlin Dong, Neelakantan Sunder, Dennis W. Burke, Diana Escobar, Yiying Zhang and Edward R. Marcantonio

    Version of Record online : 9 APR 2014, DOI: 10.1002/acn3.58

  8. Cerebrospinal fluid tau, phospho-tau181 and β-amyloid1−42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease

    European Journal of Neurology

    Volume 14, Issue 2, February 2007, Pages: 168–173, E. N. Kapaki, G. P. Paraskevas, N. G. Tzerakis, C. Sfagos, A. Seretis, E. Kararizou and D. Vassilopoulos

    Version of Record online : 23 JAN 2007, DOI: 10.1111/j.1468-1331.2006.01593.x

  9. Structure-Activity Relationships for a Series of Compounds that Inhibit Aggregation of the Alzheimer's Peptide, Aβ42

    Chemical Biology & Drug Design

    Volume 84, Issue 5, November 2014, Pages: 505–512, Angela F. McKoy, Jermont Chen, Trudi Schupbach and Michael H. Hecht

    Version of Record online : 21 MAY 2014, DOI: 10.1111/cbdd.12341

  10. You have full text access to this OnlineOpen article
    Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

    Annals of Clinical and Translational Neurology

    Volume 1, Issue 8, August 2014, Pages: 534–543, Niklas Mattsson, Philip S. Insel, Susan Landau, William Jagust, Michael Donohue, Leslie M. Shaw, John Q. Trojanowski, Henrik Zetterberg, Kaj Blennow, Michael Weiner and for the Alzheimer's Disease Neuroimaging Initiative

    Version of Record online : 19 JUL 2014, DOI: 10.1002/acn3.81

  11. You have free access to this content
    Neuroprotective effects of donepezil against Aβ42-induced neuronal toxicity are mediated through not only enhancing PP2A activity but also regulating GSK-3β and nAChRs activity

    Journal of Neurochemistry

    Volume 127, Issue 4, November 2013, Pages: 562–574, Min-Young Noh, Seong H. Koh, Sung-Min Kim, Tangui Maurice, Sae-Kwang Ku and Seung H. Kim

    Version of Record online : 17 JUN 2013, DOI: 10.1111/jnc.12319

  12. β-Amyloid Therapeutic Strategies for Alzheimer's Disease

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Bruno P. Imbimbo and Francesca Speroni

    Published Online : 14 OCT 2005, DOI: 10.1002/0471266949.bmc112

  13. You have free access to this content
    Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility

    Protein Science

    Volume 18, Issue 2, February 2009, Pages: 277–286, Li Ling Lee, HyungHo Ha, Young-Tae Chang and Matthew P. DeLisa

    Version of Record online : 15 DEC 2008, DOI: 10.1002/pro.33

  14. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease


    Volume 38, Issue 2, February 2001, Pages: 120–134, M R D'Andrea, R G Nagele, H-Y Wang, P A Peterson and D H S Lee

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1365-2559.2001.01082.x

  15. β-amyloid peptide is internalized into chick retinal neurons and alters the distribution of myosin Vb


    Volume 69, Issue 3, March 2012, Pages: 166–178, Leandro T. Oliveira, Priscila A. Matos, David William Provance Jr., Fernando G. de Mello, Leonardo R. Andrade, Martha M. Sorenson and Verônica P. Salerno

    Version of Record online : 3 FEB 2012, DOI: 10.1002/cm.21007

  16. Extracellular amyloid beta 42 causes necrosis, inhibition of nuclear division, and mitotic disruption under both folate deficient and folate replete conditions as measured by the cytokinesis-block micronucleus cytome assay

    Environmental and Molecular Mutagenesis

    Volume 55, Issue 1, January 2014, Pages: 1–14, Sau Lai Lee, Philip Thomas and Michael Fenech

    Version of Record online : 28 AUG 2013, DOI: 10.1002/em.21811

  17. Distance Measurement between Tyr10 and Met35 in Amyloid β by Site-Directed Spin-Labeling ESR Spectroscopy: Implications for the Stronger Neurotoxicity of Aβ42 than Aβ40


    Volume 8, Issue 18, December 17, 2007, Pages: 2308–2314, Kazuma Murakami, Hideyuki Hara, Yuichi Masuda, Hajime Ohigashi and Kazuhiro Irie

    Version of Record online : 19 NOV 2007, DOI: 10.1002/cbic.200700240

  18. Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease

    Annals of Neurology

    Volume 70, Issue 2, August 2011, Pages: 274–285, Rawan Tarawneh, Gina D'Angelo, Elizabeth Macy, Chengjie Xiong, Deborah Carter, Nigel J. Cairns, Anne M. Fagan, Denise Head, Mark A. Mintun, Jack H. Ladenson, Jin-Moo Lee, John C. Morris and David M. Holtzman

    Version of Record online : 5 AUG 2011, DOI: 10.1002/ana.22448

  19. Retro-Enantio N-Methylated Peptides as β-Amyloid Aggregation Inhibitors


    Volume 4, Issue 9, September 4, 2009, Pages: 1488–1494, Dolors Grillo-Bosch, Natàlia Carulla, Montse Cruz, Laia Sánchez, Rosa Pujol-Pina, Sergio Madurga, Francesc Rabanal and Ernest Giralt

    Version of Record online : 9 JUL 2009, DOI: 10.1002/cmdc.200900191

  20. Antibodies against β-amyloid reduce aβ oligomers, glycogen synthase kinase-3β activation and τ phosphorylation in vivo and in vitro

    Journal of Neuroscience Research

    Volume 83, Issue 3, 15 February 2006, Pages: 374–384, Qiu-Lan Ma, Giselle P. Lim, Marni E. Harris-White, Fusheng Yang, Surendra S. Ambegaokar, Oliver J. Ubeda, Charles G. Glabe, Bruce Teter, Sally A. Frautschy and Greg M. Cole

    Version of Record online : 29 DEC 2005, DOI: 10.1002/jnr.20734